TY - JOUR
KW - Young Adult
KW - Humans
KW - Male
KW - Adolescent
KW - Adult
KW - Female
KW - *Multimorbidity
KW - Cross-Sectional Studies
KW - Cluster Analysis
KW - United Kingdom/epidemiology
KW - *Patient Acceptance of Health Care
AU - F. Eto
AU - M. Samuel
AU - R. Henkin
AU - M. Mahesh
AU - T. Ahmad
AU - A. Angdembe
AU - Hamish McAllister-Williams
AU - P. Missier
AU - Reynolds N
AU - Barnes M
AU - S. Hull
AU - S. Finer
AU - R. Mathur
AD - Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
Northern Centre for Mood Disorders, Newcastle University, Newcastle, United Kingdom.
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, United Kingdom.
Newcastle University, Newcastle, United Kingdom.
AN - 37889900
BT - PLoS Med
C2 - PMC10610074 contributions for their work on the Genes & Health programme, by a Life Sciences Consortium that includes Astra Zeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline Research and Development Limited, Maze Therapeutics Inc, Merck Sharp & Dohme LLC, Novo Nordisk A/S, Pfizer Inc, Takeda Development Centre Americas Inc. RM is supported by Barts Charity (MGU0504). RM has received consulting fees from AMGEN unrelated to this work. RHM has received fees from American Center for Psychiatry & Neurology United Arab Emirates, British Association for Psychopharmacology, European College of Neuropsychopharmacology, International Society for Affective Disorders, Janssen, LivaNova, Lundbeck, My Tomorrows, OCM Comunicaziona s.n.c., Pfizer, Qatar International Mental Health Conference, Sunovion, Syntropharma, UK Medical Research Council and Wiley; grant support from National Institute for Health Research Efficacy and Mechanism Evaluation Panel and Health Technology Assessment Panel; and non-financial support from COMPASS Pathways and Magstim. PM is funded by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre, by NIHR AIM AI-MULTIPLY, and by NIHR ADMISSION (MR/V033654/1). NJR is funded by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre, by the NIHR Newcastle In Vitro Diagnostics Co-operative and NIHR AIM AI-MULTIPLY. N.J.R. is also a NIHR Senior Investigator, (Senior Investigator Award) NIHR200168. NJR reports grants from PSORT industrial partners as listed (http://www.psort.org.uk/); other research grants from GSK Stiefel and Novartis. MRB is funded by the National Institute for Health Research (NIHR) AIM AI-MULTIPLY Consortium (NIHR203982). MRB reports research grants from Benevolent AI, Janssen and Novartis. TA is funded by the NIHR Applied Research Collaboration North Thames Award (NIHR 200163). AA is funded by the NIHR (31672 AI-MULTIPLY, 2022-2025). RH is funded by the Health Data Research UK (grant ref: LOND1).
DO - 10.1371/journal.pmed.1004300
DP - NLM
ET - 2023/10/27
LA - eng
M1 - 10
N1 - 1549-1676
Eto, Fabiola
Orcid: 0000-0002-0203-8649
Samuel, Miriam
Orcid: 0000-0003-1258-435x
Henkin, Rafael
Orcid: 0000-0002-5511-5230
Mahesh, Meera
Orcid: 0009-0005-7417-2088
Ahmad, Tahania
Orcid: 0000-0003-3117-4428
Angdembe, Alisha
Hamish McAllister-Williams, R
Orcid: 0000-0001-9966-1834
Missier, Paolo
Orcid: 0000-0002-0978-2446
J Reynolds, Nick
Orcid: 0000-0002-6484-825x
R Barnes, Michael
Orcid: 0000-0001-9097-7381
Hull, Sally
Orcid: 0000-0002-8691-7519
Finer, Sarah
Orcid: 0000-0002-2684-4653
Mathur, Rohini
Orcid: 0000-0002-3817-8790
Journal Article
United States
PLoS Med. 2023 Oct 27;20(10):e1004300. doi: 10.1371/journal.pmed.1004300. eCollection 2023 Oct.
PY - 2023
SN - 1549-1277 (Print)
1549-1277
EP - e1004300
T2 - PLoS Med
TI - Ethnic differences in early onset multimorbidity and associations with health service use, long-term prescribing, years of life lost, and mortality: A cross-sectional study using clustering in the UK Clinical Practice Research Datalink
VL - 20
ER -